age 21 Years to 70 Years
Item
age 21 Years to 70 Years
boolean
C0001779 (UMLS CUI 2011AA)
397669002 (SNOMED CT 2011_0131)
Male and female subjects 21 through 70 years of age
Item
Male and female subjects 21 through 70 years of age
boolean
C0024554 (UMLS CUI 2011AA)
248153007 (SNOMED CT 2011_0131)
M (HL7 V3 2006_05)
C0015780 (UMLS CUI 2011AA)
248152002 (SNOMED CT 2011_0131)
F (HL7 V3 2006_05)
Type 2 diabetes duration > 6 months and < 10 years
Item
Type 2 diabetes duration > 6 months and < 10 years
boolean
C0011860 (UMLS CUI 2011AA)
44054006 (SNOMED CT 2011_0131)
10012613 (MedDRA 14.1)
E08-E13 (ICD-10-CM Version 2010)
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0449238 (UMLS CUI 2011AA)
103335007 (SNOMED CT 2011_0131)
MTHU001938 (LOINC Version 232)
C0439093 (UMLS CUI 2011AA)
276140008 (SNOMED CT 2011_0131)
GT (HL7 V3 2006_05)
C0205452 (UMLS CUI 2011AA)
68244004 (SNOMED CT 2011_0131)
C0439231 (UMLS CUI 2011AA)
258706009 (SNOMED CT 2011_0131)
MO (HL7 V3 2006_05)
C0439092 (UMLS CUI 2011AA)
276139006 (SNOMED CT 2011_0131)
LT (HL7 V3 2006_05)
C0205456 (UMLS CUI 2011AA)
3445001 (SNOMED CT 2011_0131)
C0439234 (UMLS CUI 2011AA)
258707000 (SNOMED CT 2011_0131)
Y (HL7 V3 2006_05)
7.8% < HbA1c < 10.5% if T2DM duration<= 5 years
Item
7.8% < HbA1c < 10.5% if T2DM duration<= 5 years
boolean
C0019018 (UMLS CUI 2011AA)
33601001 (SNOMED CT 2011_0131)
MTHU018890 (LOINC Version 232)
C0011860 (UMLS CUI 2011AA)
44054006 (SNOMED CT 2011_0131)
10012613 (MedDRA 14.1)
E08-E13 (ICD-10-CM Version 2010)
C0449238 (UMLS CUI 2011AA)
103335007 (SNOMED CT 2011_0131)
MTHU001938 (LOINC Version 232)
C0439090 (UMLS CUI 2011AA)
276137008 (SNOMED CT 2011_0131)
LE (HL7 V3 2006_05)
C0205451 (UMLS CUI 2011AA)
34001005 (SNOMED CT 2011_0131)
C0439234 (UMLS CUI 2011AA)
258707000 (SNOMED CT 2011_0131)
Y (HL7 V3 2006_05)
7.8% < HbA1c < 10.0% if T2DM duration > 5 years
Item
7.8% < HbA1c < 10.0% if T2DM duration > 5 years
boolean
C0019018 (UMLS CUI 2011AA)
33601001 (SNOMED CT 2011_0131)
MTHU018890 (LOINC Version 232)
C0011860 (UMLS CUI 2011AA)
44054006 (SNOMED CT 2011_0131)
10012613 (MedDRA 14.1)
E08-E13 (ICD-10-CM Version 2010)
C0449238 (UMLS CUI 2011AA)
103335007 (SNOMED CT 2011_0131)
MTHU001938 (LOINC Version 232)
C0439093 (UMLS CUI 2011AA)
276140008 (SNOMED CT 2011_0131)
GT (HL7 V3 2006_05)
C0205451 (UMLS CUI 2011AA)
34001005 (SNOMED CT 2011_0131)
C0439234 (UMLS CUI 2011AA)
258707000 (SNOMED CT 2011_0131)
Y (HL7 V3 2006_05)
BMI < 40 kg/m2
Item
Body mass index
boolean
C1305855 (UMLS CUI 2011AA)
140075008 (SNOMED CT 2011_0131)
10005894 (MedDRA 14.1)
LP35925-4 (LOINC Version 232)
Taking at least one oral anti-diabetic medication
Item
Taking at least one oral anti-diabetic medication
boolean
C1512806 (UMLS CUI 2011AA)
C0439091 (UMLS CUI 2011AA)
276138003 (SNOMED CT 2011_0131)
GE (HL7 V3 2006_05)
C0205447 (UMLS CUI 2011AA)
38112003 (SNOMED CT 2011_0131)
C1527415 (UMLS CUI 2011AA)
26643006 (SNOMED CT 2011_0131)
_OralRoute (HL7 V3 2006_05)
C0935929 (UMLS CUI 2011AA)
373245004 (SNOMED CT 2011_0131)
Patients treated with GLP-1 receptor agonist with at least one oral anti-diabetic medication may be included under the following conditions:
Item
Patients treated with GLP-1 receptor agonist with at least one oral anti-diabetic medication may be included under the following conditions:
boolean
CL415147 (UMLS CUI 2011AA)
C2917359 (UMLS CUI 2011AA)
C0439091 (UMLS CUI 2011AA)
276138003 (SNOMED CT 2011_0131)
GE (HL7 V3 2006_05)
C0205447 (UMLS CUI 2011AA)
38112003 (SNOMED CT 2011_0131)
C1527415 (UMLS CUI 2011AA)
26643006 (SNOMED CT 2011_0131)
_OralRoute (HL7 V3 2006_05)
C0935929 (UMLS CUI 2011AA)
373245004 (SNOMED CT 2011_0131)
C1302261 (UMLS CUI 2011AA)
399223003 (SNOMED CT 2011_0131)
C0332282 (UMLS CUI 2011AA)
255260001 (SNOMED CT 2011_0131)
C1705253 (UMLS CUI 2011AA)
a. The HbA1c, before GLP-1 receptor agonist therapy was administered, was: i. 7.8% < HbA1c < 10.5% if T2DM duration < 5 years ii. 7.8% < HbA1c < 10.0% if T2DM duration > 5 years
Item
a. The HbA1c, before GLP-1 receptor agonist therapy was administered, was: i. 7.8% < HbA1c < 10.5% if T2DM duration < 5 years ii. 7.8% < HbA1c < 10.0% if T2DM duration > 5 years
boolean
C1533734 (UMLS CUI 2011AA)
416118004 (SNOMED CT 2011_0131)
C0019018 (UMLS CUI 2011AA)
33601001 (SNOMED CT 2011_0131)
MTHU018890 (LOINC Version 232)
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C2917359 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
b. The patient was on GLP-1 receptor agonist therapy for no more than 12 weeks
Item
b. The patient was on GLP-1 receptor agonist therapy for no more than 12 weeks
boolean
C2917359 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
C0439090 (UMLS CUI 2011AA)
276137008 (SNOMED CT 2011_0131)
LE (HL7 V3 2006_05)
C0205458 (UMLS CUI 2011AA)
82809009 (SNOMED CT 2011_0131)
C0439230 (UMLS CUI 2011AA)
258705008 (SNOMED CT 2011_0131)
WK (HL7 V3 2006_05)
Women with childbearing potential (i.e., not post-menopausal or surgically sterilized) must agree to use adequate birth control methods
Item
Women with childbearing potential (i.e., not post-menopausal or surgically sterilized) must agree to use adequate birth control methods
boolean
C0043210 (UMLS CUI 2011AA)
224526002 (SNOMED CT 2011_0131)
C1148523 (UMLS CUI 2011AA)
C0237399 (UMLS CUI 2011AA)
C0680240 (UMLS CUI 2011AA)
C0700589 (UMLS CUI 2011AA)
146680009 (SNOMED CT 2011_0131)
10010808 (MedDRA 14.1)
C1518422 (UMLS CUI 2011AA)
C0232970 (UMLS CUI 2011AA)
76498008 (SNOMED CT 2011_0131)
C0015787 (UMLS CUI 2011AA)
169549004 (SNOMED CT 2011_0131)
10056199 (MedDRA 14.1)
If subject is taking lipid-lowering medication, the treatment must be stable for at least one month prior to enrollment
Item
If subject is taking lipid-lowering medication, the treatment must be stable for at least one month prior to enrollment
boolean
C0750557 (UMLS CUI 2011AA)
C1512806 (UMLS CUI 2011AA)
C0003367 (UMLS CUI 2011AA)
57952007 (SNOMED CT 2011_0131)
C0039798 (UMLS CUI 2011AA)
C0027552 (UMLS CUI 2011AA)
410525008 (SNOMED CT 2011_0131)
C0205360 (UMLS CUI 2011AA)
58158008 (SNOMED CT 2011_0131)
MTHU015276 (LOINC Version 232)
If subject is taking anti-hypertensive medication, the treatment must be stable for at least one month prior to enrollment
Item
If subject is taking anti-hypertensive medication, the treatment must be stable for at least one month prior to enrollment
boolean
C0750557 (UMLS CUI 2011AA)
C1512806 (UMLS CUI 2011AA)
C0003364 (UMLS CUI 2011AA)
372586001 (SNOMED CT 2011_0131)
C0039798 (UMLS CUI 2011AA)
C0027552 (UMLS CUI 2011AA)
410525008 (SNOMED CT 2011_0131)
C0205360 (UMLS CUI 2011AA)
58158008 (SNOMED CT 2011_0131)
MTHU015276 (LOINC Version 232)
If subject is taking anti-depressant medication, the treatment must be stable for at least one month prior to enrollment
Item
If subject is taking anti-depressant medication, the treatment must be stable for at least one month prior to enrollment
boolean
C0750557 (UMLS CUI 2011AA)
C1512806 (UMLS CUI 2011AA)
C0003289 (UMLS CUI 2011AA)
372720008 (SNOMED CT 2011_0131)
MTHU006782 (LOINC Version 232)
C0039798 (UMLS CUI 2011AA)
C0027552 (UMLS CUI 2011AA)
410525008 (SNOMED CT 2011_0131)
C0205360 (UMLS CUI 2011AA)
58158008 (SNOMED CT 2011_0131)
MTHU015276 (LOINC Version 232)
Willingness to refrain from using prescription, over the counter, or herbal weight loss products for the duration of the trial
Item
Willingness to refrain from using prescription, over the counter, or herbal weight loss products for the duration of the trial
boolean
C0600109 (UMLS CUI 2011AA)
225466006 (SNOMED CT 2011_0131)
C0870186 (UMLS CUI 2011AA)
C0033080 (UMLS CUI 2011AA)
16076005 (SNOMED CT 2011_0131)
C0013231 (UMLS CUI 2011AA)
329505003, 80288002 (SNOMED CT 2011_0131)
C0376606 (UMLS CUI 2011AA)
C1572271 (UMLS CUI 2011AA)
Ability and willingness to perform required study and data collection procedures and adhere to operating requirements of the TANTALUS® System
Item
Ability and willingness to perform required study and data collection procedures and adhere to operating requirements of the TANTALUS® System
boolean
C0085732 (UMLS CUI 2011AA)
371150009 (SNOMED CT 2011_0131)
C0600109 (UMLS CUI 2011AA)
225466006 (SNOMED CT 2011_0131)
C0884358 (UMLS CUI 2011AA)
398166005 (SNOMED CT 2011_0131)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
C0010995 (UMLS CUI 2011AA)
C2700391 (UMLS CUI 2011AA)
C0525058 (UMLS CUI 2011AA)
Alert, mentally competent, and able to understand and willing to comply with the requirements of the clinical trial, and personally motivated to abide by the requirements and restrictions of the clinical trial
Item
Alert, mentally competent, and able to understand and willing to comply with the requirements of the clinical trial, and personally motivated to abide by the requirements and restrictions of the clinical trial
boolean
C0086035 (UMLS CUI 2011AA)
32082000 (SNOMED CT 2011_0131)
C1273101 (UMLS CUI 2011AA)
395659009 (SNOMED CT 2011_0131)
C0600109 (UMLS CUI 2011AA)
225466006 (SNOMED CT 2011_0131)
C1321605 (UMLS CUI 2011AA)
405078008 (SNOMED CT 2011_0131)
C1514873 (UMLS CUI 2011AA)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
Able to provide voluntary informed consent
Item
Able to provide voluntary informed consent
boolean
C0085732 (UMLS CUI 2011AA)
371150009 (SNOMED CT 2011_0131)
C0184704 (UMLS CUI 2011AA)
55149002 (SNOMED CT 2011_0131)
Insulin therapy within the last 3 months
Item
Insulin therapy within the last 3 months
boolean
C0021641 (UMLS CUI 2011AA)
67866001 (SNOMED CT 2011_0131)
MTHU019392 (LOINC Version 232)
C0039798 (UMLS CUI 2011AA)
GLP-1 receptor agonist therapy longer than 3 months
Item
GLP-1 receptor agonist therapy longer than 3 months
boolean
C2917359 (UMLS CUI 2011AA)
C0039798 (UMLS CUI 2011AA)
Diagnosed with renal dysfunction or history of renal dysfunction
Item
Diagnosed with renal dysfunction or history of renal dysfunction
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C1848822 (UMLS CUI 2011AA)
Taking medications known to affect gastric motility
Item
Taking medications known to affect gastric motility
boolean
C1512806 (UMLS CUI 2011AA)
C0013227 (UMLS CUI 2011AA)
C0392760 (UMLS CUI 2011AA)
247591002 (SNOMED CT 2011_0131)
C0232572 (UMLS CUI 2011AA)
36735000 (SNOMED CT 2011_0131)
Use of prescription, over the counter or herbal weight loss products or obesity drugs during the past two months
Item
Use of prescription, over the counter or herbal weight loss products or obesity drugs during the past two months
boolean
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C0033080 (UMLS CUI 2011AA)
16076005 (SNOMED CT 2011_0131)
C0013231 (UMLS CUI 2011AA)
329505003, 80288002 (SNOMED CT 2011_0131)
C0376606 (UMLS CUI 2011AA)
C1572271 (UMLS CUI 2011AA)
C0376607 (UMLS CUI 2011AA)
Experiencing severe and progressing diabetic complications
Item
Experiencing severe and progressing diabetic complications
boolean
C0205082 (UMLS CUI 2011AA)
24484000 (SNOMED CT 2011_0131)
C0342257 (UMLS CUI 2011AA)
74627003 (SNOMED CT 2011_0131)
10061104 (MedDRA 14.1)
250.9 (ICD-9-CM Version 2011)
Prior wound healing problems
Item
Prior wound healing problems
boolean
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C1096106 (UMLS CUI 2011AA)
10053692 (MedDRA 14.1)
E12057 (CTCAE 1105E)
Diagnosed with past or current psychiatric condition that may impair his or her ability to comply with the study procedures
Item
Diagnosed with past or current psychiatric condition that may impair his or her ability to comply with the study procedures
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0278060 (UMLS CUI 2011AA)
36456004 (SNOMED CT 2011_0131)
MTHU001424 (LOINC Version 232)
MTHU117157 (CTCAE 1105E)
C0221099 (UMLS CUI 2011AA)
260379002 (SNOMED CT 2011_0131)
C0085732 (UMLS CUI 2011AA)
371150009 (SNOMED CT 2011_0131)
C0525058 (UMLS CUI 2011AA)
Use of anti-psychotic medications
Item
Use of anti-psychotic medications
boolean
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C0040615 (UMLS CUI 2011AA)
10784006, 372482001 (SNOMED CT 2011_0131)
MTHU003337 (LOINC Version 232)
Diagnosed with eating disorder such as bulimia or binge eating
Item
Diagnosed with eating disorder such as bulimia or binge eating
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0013473 (UMLS CUI 2011AA)
72366004 (SNOMED CT 2011_0131)
10014062 (MedDRA 14.1)
F50.9 (ICD-10-CM Version 2010)
307.50 (ICD-9-CM Version 2011)
C0006370 (UMLS CUI 2011AA)
78004001 (SNOMED CT 2011_0131)
10006549 (MedDRA 14.1)
F50.2 (ICD-10-CM Version 2010)
C0596170 (UMLS CUI 2011AA)
439960005 (SNOMED CT 2011_0131)
F50.2 (ICD-10-CM Version 2010)
Obesity due to an endocrinopathy
Item
Obesity due to an endocrinopathy
boolean
C0028754 (UMLS CUI 2011AA)
414916001 (SNOMED CT 2011_0131)
10029883 (MedDRA 14.1)
E66.0 (ICD-10-CM Version 2010)
278.00 (ICD-9-CM Version 2011)
E12361 (CTCAE 1105E)
CL420107 (UMLS CUI 2011AA)
C0014130 (UMLS CUI 2011AA)
362969004 (SNOMED CT 2011_0131)
10014695 (MedDRA 14.1)
MTHU021570 (LOINC Version 232)
E34.9 (ICD-10-CM Version 2010)
259.9 (ICD-9-CM Version 2011)
Hiatal hernia requiring surgical repair or a paraesophageal hernia
Item
Hiatal hernia requiring surgical repair or a paraesophageal hernia
boolean
CL432890 (UMLS CUI 2011AA)
C1514873 (UMLS CUI 2011AA)
C0374711 (UMLS CUI 2011AA)
4365001 (SNOMED CT 2011_0131)
C0267725 (UMLS CUI 2011AA)
3662000 (SNOMED CT 2011_0131)
10059188 (MedDRA 14.1)
K44 (ICD-10-CM Version 2010)
Pregnant or lactating
Item
Pregnant or lactating
boolean
C0549206 (UMLS CUI 2011AA)
10036586 (MedDRA 14.1)
C2828358 (UMLS CUI 2011AA)
Diagnosed with impaired liver function
Item
Diagnosed with impaired liver function
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0086565 (UMLS CUI 2011AA)
75183008 (SNOMED CT 2011_0131)
10019670 (MedDRA 14.1)
Any prior bariatric surgery
Item
Any prior bariatric surgery
boolean
C0332152 (UMLS CUI 2011AA)
288556008 (SNOMED CT 2011_0131)
C1456587 (UMLS CUI 2011AA)
10068900 (MedDRA 14.1)
Any history of pancreatitis
Item
Any history of pancreatitis
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0030305 (UMLS CUI 2011AA)
75694006 (SNOMED CT 2011_0131)
10033645 (MedDRA 14.1)
K85.9 (ICD-10-CM Version 2010)
577.0 (ICD-9-CM Version 2011)
E10930 (CTCAE 1105E)
Any history of peptic ulcer disease within 5 years of enrollment
Item
Personal history of peptic ulcer disease
boolean
C0375803 (UMLS CUI 2011AA)
Z87.11 (ICD-10-CM Version 2010)
V12.71 (ICD-9-CM Version 2011)
Diagnosed with Gastroparesis or other GI motility disorder
Item
Diagnosed with Gastroparesis or other GI motility disorder
boolean
C0011900 (UMLS CUI 2011AA)
439401001 (SNOMED CT 2011_0131)
MTHU008876 (LOINC Version 232)
C0152020 (UMLS CUI 2011AA)
235675006 (SNOMED CT 2011_0131)
10018043 (MedDRA 14.1)
536.3 (ICD-9-CM Version 2011)
E10759 (CTCAE 1105E)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C0854121 (UMLS CUI 2011AA)
10061173 (MedDRA 14.1)
Use of active medical devices (either implantable or external) such as ICD, drug infusion device, or neurostimulator (either implanted or worn).
Item
Use of active medical devices (either implantable or external) such as ICD, drug infusion device, or neurostimulator (either implanted or worn).
boolean
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
C0025080 (UMLS CUI 2011AA)
63653004 (SNOMED CT 2011_0131)
MTHU032523 (LOINC Version 232)
C0162589 (UMLS CUI 2011AA)
72506001 (SNOMED CT 2011_0131)
C0013187 (UMLS CUI 2011AA)
C0582124 (UMLS CUI 2011AA)
25937001 (SNOMED CT 2011_0131)
Subjects using an external active device who are able and willing to avoid use of the device during the study may be enrolled.
Item
Subjects using an external active device who are able and willing to avoid use of the device during the study may be enrolled.
boolean
C1516879 (UMLS CUI 2011AA)
C0750557 (UMLS CUI 2011AA)
C0085732 (UMLS CUI 2011AA)
371150009 (SNOMED CT 2011_0131)
C0600109 (UMLS CUI 2011AA)
225466006 (SNOMED CT 2011_0131)
C0870186 (UMLS CUI 2011AA)
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C0205177 (UMLS CUI 2011AA)
55561003 (SNOMED CT 2011_0131)
CL381648 (UMLS CUI 2011AA)
Cardiac history that physician feels should exclude the subject from the study.
Item
Cardiac history that physician feels should exclude the subject from the study.
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C0018799 (UMLS CUI 2011AA)
56265001 (SNOMED CT 2011_0131)
10061024 (MedDRA 14.1)
C0022423 (UMLS CUI 2011AA)
61254005 (SNOMED CT 2011_0131)
C0031831 (UMLS CUI 2011AA)
309343006 (SNOMED CT 2011_0131)
MTHU010489 (LOINC Version 232)
PHYS (HL7 V3 2006_05)
CL411789 (UMLS CUI 2011AA)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)
Use of another investigational device or agent in the 30 days prior to enrollment
Item
Use of another investigational device or agent in the 30 days prior to enrollment
boolean
C1524063 (UMLS CUI 2011AA)
260676000 (SNOMED CT 2011_0131)
C0205394 (UMLS CUI 2011AA)
74964007 (SNOMED CT 2011_0131)
C2346570 (UMLS CUI 2011AA)
C0013230 (UMLS CUI 2011AA)
A history of life-threatening disease within 5 years of enrollment
Item
A history of life-threatening disease within 5 years of enrollment
boolean
CL421546 (UMLS CUI 2011AA)
392521001 (SNOMED CT 2011_0131)
C2826244 (UMLS CUI 2011AA)
C0012634 (UMLS CUI 2011AA)
64572001 (SNOMED CT 2011_0131)
Any additional condition(s) that in the Investigator's opinion would warrant exclusion from the study or prevent the subject from completing the study
Item
Any additional condition(s) that in the Investigator's opinion would warrant exclusion from the study or prevent the subject from completing the study
boolean
C1524062 (UMLS CUI 2011AA)
MTHU013802 (LOINC Version 232)
C0348080 (UMLS CUI 2011AA)
260905004 (SNOMED CT 2011_0131)
COND (HL7 V3 2006_05)
C0678227 (UMLS CUI 2011AA)
23981006 (SNOMED CT 2011_0131)
CL411789 (UMLS CUI 2011AA)
CL414898 (UMLS CUI 2011AA)
C0681850 (UMLS CUI 2011AA)
C1554962 (UMLS CUI 2011AA)
C (HL7 V3 2006_05)
C0008976 (UMLS CUI 2011AA)
110465008 (SNOMED CT 2011_0131)